Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ENOV Enovis	$31.41 -2.8%	$38.29	$29.32 ▼ $57.08	$1.79B	1.86	734,468 shs	798,270 shs
KIDS OrthoPediatrics	$20.97 0.0%	$24.07	$20.37 ▼ $35.99	$509.30M	1.17	198,291 shs	143,503 shs
LIVN LivaNova	$34.80 -1.9%	$40.84	$32.48 ▼ $64.48	$1.89B	0.9	623,677 shs	545,986 shs
LMAT LeMaitre Vascular	$84.63 +1.0%	$88.58	$62.39 ▼ $109.58	$1.89B	0.89	158,970 shs	145,216 shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ENOV Enovis	-2.70%	+2.65%	-15.14%	-31.28%	-44.73%
KIDS OrthoPediatrics	-0.05%	-3.67%	-16.39%	-19.59%	-31.13%
LIVN LivaNova	-1.86%	+2.81%	-11.31%	-26.94%	-34.79%
LMAT LeMaitre Vascular	+1.01%	+8.65%	+3.32%	-13.43%	+31.31%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ENOV Enovis	2.2227 of 5 stars	3.4	1.0	0.0	0.0	1.5	1.7	1.9
KIDS OrthoPediatrics	4.322 of 5 stars	3.4	4.0	0.0	3.9	1.8	4.2	0.6
LIVN LivaNova	3.555 of 5 stars	4.4	3.0	0.0	0.0	2.9	1.7	1.3
LMAT LeMaitre Vascular	3.0974 of 5 stars	2.3	1.0	3.3	0.0	4.2	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ENOV Enovis	2.75	Moderate Buy	$58.50	86.26% Upside
KIDS OrthoPediatrics	2.80	Moderate Buy	$37.00	76.44% Upside
LIVN LivaNova	2.88	Moderate Buy	$61.17	75.77% Upside
LMAT LeMaitre Vascular	2.67	Moderate Buy	$95.25	12.55% Upside

Current Analyst Ratings Breakdown

Latest KIDS, LIVN, LMAT, and ENOV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$64.00 ➝ $64.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
4/2/2025	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$64.00 ➝ $64.00
3/17/2025	LIVN LivaNova	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$64.00 ➝ $64.00
3/7/2025	LIVN LivaNova	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$58.00 ➝ $56.00
3/5/2025	KIDS OrthoPediatrics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $32.00
3/5/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
3/3/2025	LIVN LivaNova	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$64.00 ➝ $55.00
2/28/2025	LMAT LeMaitre Vascular	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$105.00 ➝ $110.00

(Data available from 4/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ENOV Enovis	$2.11B	0.85	$4.58 per share	6.86	$62.66 per share	0.50
KIDS OrthoPediatrics	$204.73M	2.49	N/A	N/A	$16.14 per share	1.30
LIVN LivaNova	$1.25B	1.51	$3.12 per share	11.15	$23.72 per share	1.47
LMAT LeMaitre Vascular	$219.86M	8.68	$1.50 per share	56.52	$13.38 per share	6.33

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ENOV Enovis	-$33.26M	-$14.29	N/A	9.85	N/A	-5.95%	4.39%	2.80%	5/1/2025 (Estimated)
KIDS OrthoPediatrics	-$20.97M	-$1.63	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	5/5/2025 (Estimated)
LIVN LivaNova	$17.55M	$1.14	82.86	11.08	N/A	1.91%	13.81%	7.07%	4/29/2025 (Estimated)
LMAT LeMaitre Vascular	$30.10M	$1.94	46.25	39.00	2.22	19.40%	13.15%	11.47%	5/1/2025 (Estimated)

Latest KIDS, LIVN, LMAT, and ENOV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	LIVN LivaNova	$0.75	N/A	N/A	N/A	$302.34 million	N/A
5/5/2025	Q1 2025	KIDS OrthoPediatrics	-$0.38	N/A	N/A	N/A	$51.68 million	N/A
5/1/2025	Q1 2025	ENOV Enovis	$0.74	N/A	N/A	N/A	$558.80 million	N/A
5/1/2025	Q1 2025	LMAT LeMaitre Vascular	$0.50	N/A	N/A	N/A	$57.61 million	N/A
3/4/2025	Q4 2024	KIDS OrthoPediatrics	-$0.33	-$0.29	+$0.04	-$0.69	$51.16 million	$52.67 million
2/27/2025	Q4 2024	LMAT LeMaitre Vascular	$0.49	$0.49	N/A	$0.49	$55.99 million	$55.81 million
2/26/2025	Q4 2024	ENOV Enovis	$0.92	$0.98	+$0.06	-$12.05	$555.14 million	$560.98 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$0.80	0.95%	+13.30%	41.24%	14 Years

Latest KIDS, LIVN, LMAT, and ENOV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/18/2025	LMAT LeMaitre Vascular	quarterly	$0.20	0.9%	3/13/2025	3/13/2025	3/27/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ENOV Enovis	0.40	2.27	1.12
KIDS OrthoPediatrics	0.19	7.17	3.68
LIVN LivaNova	0.46	3.37	2.87
LMAT LeMaitre Vascular	N/A	7.74	5.52

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ENOV Enovis	98.45%
KIDS OrthoPediatrics	69.05%
LIVN LivaNova	97.64%
LMAT LeMaitre Vascular	84.64%

Insider Ownership

Company	Insider Ownership
ENOV Enovis	2.40%
KIDS OrthoPediatrics	31.80%
LIVN LivaNova	0.27%
LMAT LeMaitre Vascular	10.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ENOV Enovis	6,800	56.96 million	55.49 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable
LIVN LivaNova	2,900	54.35 million	54.15 million	Optionable
LMAT LeMaitre Vascular	490	22.56 million	20.06 million	Optionable

KIDS, LIVN, LMAT, and ENOV Headlines

Recent News About These Companies

Federated Hermes Inc. Grows Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 15 at 4:48 AM | marketbeat.com

Envestnet Asset Management Inc. Has $23.90 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 15 at 3:48 AM | marketbeat.com

Geode Capital Management LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 15 at 3:39 AM | marketbeat.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Arrowstreet Capital Limited Partnership

April 14 at 3:37 AM | marketbeat.com

JPMorgan Chase & Co. Boosts Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 14 at 3:29 AM | marketbeat.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by F M Investments LLC

April 13 at 6:16 AM | marketbeat.com

Russell Investments Group Ltd. Sells 54,184 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 12, 2025 | marketbeat.com

Ranger Investment Management L.P. Sells 27,226 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 11, 2025 | marketbeat.com

LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock?

April 10, 2025 | zacks.com

LeMaitre Vascular (NASDAQ:LMAT) Stock Price Down 10.5% - Here's What Happened

April 9, 2025 | marketbeat.com

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

April 7, 2025 | globenewswire.com

Integrated Quantitative Investments LLC Invests $912,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 6, 2025 | marketbeat.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by DF Dent & Co. Inc.

April 5, 2025 | marketbeat.com

4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues

April 4, 2025 | zacks.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Brokerages

April 3, 2025 | marketbeat.com

KLP Kapitalforvaltning AS Invests $811,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

April 2, 2025 | marketbeat.com

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

April 1, 2025 | globenewswire.com

2 Reasons to Avoid LMAT and 1 Stock to Buy Instead

March 31, 2025 | msn.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Sei Investments Co.

March 31, 2025 | marketbeat.com

Quantbot Technologies LP Has $336,000 Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

March 30, 2025 | marketbeat.com

Segall Bryant & Hamill LLC Acquires New Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

March 29, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, LIVN, LMAT, and ENOV Company Descriptions

Enovis NYSE:ENOV

$31.41 -0.90 (-2.79%)

Closing price 04/15/2025 03:59 PM Eastern

Extended Trading

$31.48 +0.08 (+0.25%)

As of 04:09 AM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

OrthoPediatrics NASDAQ:KIDS

$20.97 -0.01 (-0.05%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$20.98 +0.01 (+0.02%)

As of 04:13 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

LivaNova NASDAQ:LIVN

$34.80 -0.66 (-1.86%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$34.76 -0.04 (-0.11%)

As of 04:01 AM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LeMaitre Vascular NASDAQ:LMAT

$84.63 +0.85 (+1.01%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$84.62 -0.01 (-0.01%)

As of 04:15 AM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time